TOE1_HUMAN - dbPTM
TOE1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TOE1_HUMAN
UniProt AC Q96GM8
Protein Name Target of EGR1 protein 1
Gene Name TOE1
Organism Homo sapiens (Human).
Sequence Length 510
Subcellular Localization Nucleus, nucleolus . Nucleus speckle . Localizes to nuclear speckles.
Protein Description Inhibits cell growth rate and cell cycle. Induces CDKN1A expression as well as TGF-beta expression. Mediates the inhibitory growth effect of EGR1. Involved in the maturation of snRNAs and snRNA 3'-tail processing. [PubMed: 28092684]
Protein Sequence MAADSDDGAVSAPAASDGGVSKSTTSGEELVVQVPVVDVQSNNFKEMWPSLLLAIKTANFVAVDTELSGLGDRKSLLNQCIEERYKAVCHAARTRSILSLGLACFKRQPDKGEHSYLAQVFNLTLLCMEEYVIEPKSVQFLIQHGFNFNQQYAQGIPYHKGNDKGDESQSQSVRTLFLELIRARRPLVLHNGLIDLVFLYQNFYAHLPESLGTFTADLCEMFPAGIYDTKYAAEFHARFVASYLEYAFRKCERENGKQRAAGSPHLTLEFCNYPSSMRDHIDYRCCLPPATHRPHPTSICDNFSAYGWCPLGPQCPQSHDIDLIIDTDEAAAEDKRRRRRRREKRKRALLNLPGTQTSGEAKDGPPKKQVCGDSIKPEETEQEVAADETRNLPHSKQGNKNDLEMGIKAARPEIADRATSEVPGSQASPNPVPGDGLHRAGFDAFMTGYVMAYVEVSQGPQPCSSGPWLPECHNKVYLSGKAVPLTVAKSQFSRSSKAHNQKMKLTWGSS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAADSDDGA
------CCCCCCCCC
21.7019413330
5Phosphorylation---MAADSDDGAVSA
---CCCCCCCCCCCC
32.6429255136
11PhosphorylationDSDDGAVSAPAASDG
CCCCCCCCCCCCCCC
28.1822167270
16PhosphorylationAVSAPAASDGGVSKS
CCCCCCCCCCCCCCC
38.6023403867
21PhosphorylationAASDGGVSKSTTSGE
CCCCCCCCCCCCCCC
24.9423403867
33UbiquitinationSGEELVVQVPVVDVQ
CCCCEEEEEEEEECC
26.7322817900
37UbiquitinationLVVQVPVVDVQSNNF
EEEEEEEEECCCCCH
4.9622817900
74UbiquitinationLSGLGDRKSLLNQCI
CCCCCCHHHHHHHHH
50.6329967540
75O-linked_GlycosylationSGLGDRKSLLNQCIE
CCCCCHHHHHHHHHH
38.7030379171
84UbiquitinationLNQCIEERYKAVCHA
HHHHHHHHHHHHHHH
26.01-
96PhosphorylationCHAARTRSILSLGLA
HHHHHHHHHHHHEEH
27.5428450419
99PhosphorylationARTRSILSLGLACFK
HHHHHHHHHEEHHHH
20.7928450419
106AcetylationSLGLACFKRQPDKGE
HHEEHHHHCCCCCCC
50.4326051181
114UbiquitinationRQPDKGEHSYLAQVF
CCCCCCCCCHHHHHH
30.3422817900
118UbiquitinationKGEHSYLAQVFNLTL
CCCCCHHHHHHHHHE
8.6822817900
160UbiquitinationAQGIPYHKGNDKGDE
HCCCCCCCCCCCCCH
54.2722817900
164AcetylationPYHKGNDKGDESQSQ
CCCCCCCCCCHHHHH
72.7226051181
164UbiquitinationPYHKGNDKGDESQSQ
CCCCCCCCCCHHHHH
72.7222817900
166UbiquitinationHKGNDKGDESQSQSV
CCCCCCCCHHHHHHH
59.1022817900
170UbiquitinationDKGDESQSQSVRTLF
CCCCHHHHHHHHHHH
33.4322817900
354UbiquitinationRALLNLPGTQTSGEA
HHHHCCCCCCCCCCC
33.3522505724
355PhosphorylationALLNLPGTQTSGEAK
HHHCCCCCCCCCCCC
27.0821712546
357PhosphorylationLNLPGTQTSGEAKDG
HCCCCCCCCCCCCCC
38.2425159151
358PhosphorylationNLPGTQTSGEAKDGP
CCCCCCCCCCCCCCC
25.4825159151
368AcetylationAKDGPPKKQVCGDSI
CCCCCCCCCCCCCCC
54.4526051181
368UbiquitinationAKDGPPKKQVCGDSI
CCCCCCCCCCCCCCC
54.4529967540
374PhosphorylationKKQVCGDSIKPEETE
CCCCCCCCCCHHHHH
20.1423312004
376AcetylationQVCGDSIKPEETEQE
CCCCCCCCHHHHHHH
50.7826051181
376UbiquitinationQVCGDSIKPEETEQE
CCCCCCCCHHHHHHH
50.7829967540
401UbiquitinationHSKQGNKNDLEMGIK
HHCCCCHHHHHHHHH
64.20-
419PhosphorylationPEIADRATSEVPGSQ
HHHHHHCCCCCCCCC
26.7229255136
420PhosphorylationEIADRATSEVPGSQA
HHHHHCCCCCCCCCC
35.3030266825
425PhosphorylationATSEVPGSQASPNPV
CCCCCCCCCCCCCCC
19.2623401153
428PhosphorylationEVPGSQASPNPVPGD
CCCCCCCCCCCCCCC
19.9923401153
435UbiquitinationSPNPVPGDGLHRAGF
CCCCCCCCCCCCCCC
50.8722505724
481AcetylationNKVYLSGKAVPLTVA
CEEEECCCEEECCHH
42.7226051181
481UbiquitinationNKVYLSGKAVPLTVA
CEEEECCCEEECCHH
42.7222505724
487UbiquitinationGKAVPLTVAKSQFSR
CCEEECCHHHHHHCC
9.2222505724
489UbiquitinationAVPLTVAKSQFSRSS
EEECCHHHHHHCCCC
40.2229967540
509PhosphorylationKMKLTWGSS------
CCCCEECCC------
25.1621712546
510PhosphorylationMKLTWGSS-------
CCCEECCC-------
40.0622617229

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of TOE1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TOE1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TOE1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
APLP1_HUMANAPLP1physical
16169070
SUMO1_HUMANSUMO1physical
16169070
RS3A_HUMANRPS3Aphysical
16169070
SH3G3_HUMANSH3GL3physical
16169070
PYM1_HUMANWIBGphysical
22939629
SF3B2_HUMANSF3B2physical
22365833
SF3B3_HUMANSF3B3physical
22365833
U2AF1_HUMANU2AF1physical
22365833
RBM39_HUMANRBM39physical
22365833
SRSF6_HUMANSRSF6physical
22365833
LSM4_HUMANLSM4physical
22365833
PRCC_HUMANPRCCphysical
22365833
RED_HUMANIKphysical
22365833
RBM8A_HUMANRBM8Aphysical
22365833
WDR83_HUMANWDR83physical
22365833
PP1A_HUMANPPP1CAphysical
22365833
AGGF1_HUMANAGGF1physical
22365833
MEP50_HUMANWDR77physical
22365833
HNRPF_HUMANHNRNPFphysical
22365833
IL7RA_HUMANIL7Rphysical
23151878

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TOE1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-5, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-5, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5, AND MASSSPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5, AND MASSSPECTROMETRY.

TOP